128 related articles for article (PubMed ID: 19816088)
1. Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Tamura T; Kimoto N
Pharmacology; 2009; 84(5):288-93. PubMed ID: 19816088
[TBL] [Abstract][Full Text] [Related]
2. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Tamura T; Komai M
Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
[TBL] [Abstract][Full Text] [Related]
4. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.
Tamura T; Matsubara M; Takada C; Hasegawa K; Suzuki K; Ohmori K; Karasawa A
Br J Dermatol; 2004 Dec; 151(6):1133-42. PubMed ID: 15606507
[TBL] [Abstract][Full Text] [Related]
5. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
6. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
7. Olopatadine nasal spray for the treatment of allergic rhinitis.
Roland PS; Marple BF; Wall GM
Expert Rev Clin Immunol; 2010 Mar; 6(2):197-204. PubMed ID: 20402382
[TBL] [Abstract][Full Text] [Related]
8. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
Roland PS; Ryan MW; Wall GM
Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
[TBL] [Abstract][Full Text] [Related]
9. Repeated pre-treatment with antihistamines suppresses [corrected] transcriptional up-regulations of histamine H(1) receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats.
Mizuguchi H; Hatano M; Matsushita C; Umehara H; Kuroda W; Kitamura Y; Takeda N; Fukui H
J Pharmacol Sci; 2008 Dec; 108(4):480-6. PubMed ID: 19075512
[TBL] [Abstract][Full Text] [Related]
10. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
Tamura T; Amano T; Ohmori K; Manabe H
Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
[TBL] [Abstract][Full Text] [Related]
11. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.
Berger W; Abelson MB; Gomes PJ; Beck M; Kimura S; Westbrook T; Storms W; Galant S
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):361-71. PubMed ID: 16279567
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
[TBL] [Abstract][Full Text] [Related]
13. Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
Ohmori K; Hasegawa K; Tamura T; Miyake K; Matsubara M; Masaki S; Karasawa A; Urayama N; Horikoshi K; Kajita J; Hasegawa M; Taniguchi K; Komada T; Kawamoto Y
Arzneimittelforschung; 2004; 54(12):809-29. PubMed ID: 15646365
[TBL] [Abstract][Full Text] [Related]
14. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
Tamura T; Matsubara M; Hasegawa K; Ohmori K; Karasawa A
Clin Exp Allergy; 2005 Jan; 35(1):97-103. PubMed ID: 15649273
[TBL] [Abstract][Full Text] [Related]
15. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
16. Drug approvals: '08 in review. Olopatadine hydrochloride (Patanase) nasal spray.
Laustsen G; Carrillo F; Johnson J; Smith C
Nurse Pract; 2009 Feb; 34(2):29. PubMed ID: 19155880
[No Abstract] [Full Text] [Related]
17. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
[TBL] [Abstract][Full Text] [Related]
18. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
Senda M; Kubo N; Adachi K; Ikari Y; Matsumoto K; Shimizu K; Tominaga H
J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
[TBL] [Abstract][Full Text] [Related]
19. Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.
Amano T; Takeda T; Yano H; Tamura T
Br J Dermatol; 2007 May; 156(5):906-12. PubMed ID: 17355233
[TBL] [Abstract][Full Text] [Related]
20. Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function.
Tamura T; Matsubara M; Amano T; Chida M
Pharmacology; 2008; 81(2):118-26. PubMed ID: 17962722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
